DNAJC1 and glioma: Overall, our research underscores DNAJC1’s pivotal role in glioma pathogenesis and underscores its potential as a significant prognostic biomarker and a candidate for targeted therapy, opening new pathways for advancing glioma diagnostics and treatment.